The GeCIP Board is tasked with overseeing and steering GeCIP. It is comprised of:
- representatives from funders (National Institute for Health Research, Wellcome Trust, Medical Research Council, Cancer Research UK);
- a representative from the Genomics England Scientific Advisory Committee;
- patient representative(s);
- a representative from each of the devolved nations
- and a representative from each of the Cancer, Rare Diseases, and Cross-Cutting arms of GeCIP, as decided by the GeCIP Steering Committee.
Membership
It's current membership is as follows
| Member name | Position |
|---|---|
| Kay Davies | Chair |
| Mark Caulfield | Genomics England, Chief Scientist and Deputy Chair |
| Sue Hill | NHS England, Chief Scientific Officer |
| Mark Bale | DH/NIHR |
| Michael Parker | Ethic Advisory Committee Representative |
| Michael Dunn | Wellcome Trust |
| Nathan Richardson | Medical Research Council |
| Maria A Cerone | Cancer Research UK |
| Tom Barlow | Devolved Nations Representative for Scotland |
| Jon Bisson | Devolved Nations Representative for Wales |
| Ian Young | Devolved Nations Representative for Northern Ireland |
| Colin Cooper | Cross-Cutting GeCIP Domain Representative |
| Chrissie Thirlwell | Cancer GeCIP Domain Representative |
| Henry Houlden | Rare diseases GeCIP Domain Representative |
| Leanne Leriche | Participant Panel Representative |
| Alison Fox | Participant Panel Representative |
| Dave McCormick | Participant Panel Representative |
Documentation
GeCIP Board Terms of Reference